Valuation of complex license contracts

摘要

Licensing is an important business model within the drug developmentindustry. Recently license contracts have become extremely complex, including sublicensing,co-development, or profit sharing. Traditional rules of thumb are not sufficient anymore asguidelines in negotiations of deal terms. The authors explain an easy-to-understand modelthat enables business developers to negotiate financial terms that are fair for both parties.